| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $889.9M | -4.9% |
| Cost of Revenue | $697.8M | -7.1% |
| Gross Profit | $192.1M | +4.0% |
| R&D Expense | $37.1M | +1.9% |
| SG&A Expense | $70.2M | +19.6% |
| Operating Income | -$12.6M | -46.3% |
| Pre-tax Income | $1.7M | -89.6% |
| Income Tax | $2.4M | -60.5% |
| Net Income | -$711K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.1M | +25.7% |
| Short-term Investments | $77.0M | -18.3% |
| Accounts Receivable | $149.2M | -21.2% |
| Current Assets | $343.1M | -14.6% |
| Total Assets | $549.2M | -17.4% |
| Current Liabilities | $289.5M | -2.7% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $68.6M | +398.8% |
| Capital Expenditures | $7.4M | -27.1% |
| Investing Cash Flow | $67.2M | -3.6% |
| Financing Cash Flow | -$117.7M | -0.5% |
| Free Cash Flow | $61.2M | +1590.5% |
| -106.9% |
| EPS (Basic) | -$0.01 | -105.0% |
| EPS (Diluted) | -$0.11 | -83.3% |
| Total Liabilities |
| $317.9M |
| -28.0% |
| Stockholders' Equity | $231.3M | +3.7% |